RB1 and small cell lung carcinoma: Zhang et al. (2023) employed NGS techniques for both circulating tumor DNA (ctDNA) testing and tissue sequencing; the researchers detected mutations in key genes, such as TP53, RB1, and PTEN, and the dynamic somatic mutation profile of extensive-stage small-cell lung cancer (ES-SCLC).